IBDEI0U5 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14136,0)
 ;;=D86.86^^53^603^39
 ;;^UTILITY(U,$J,358.3,14136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14136,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,14136,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,14136,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,14137,0)
 ;;=D86.87^^53^603^43
 ;;^UTILITY(U,$J,358.3,14137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14137,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,14137,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,14137,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,14138,0)
 ;;=D86.3^^53^603^49
 ;;^UTILITY(U,$J,358.3,14138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14138,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,14138,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,14138,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,14139,0)
 ;;=D86.81^^53^603^41
 ;;^UTILITY(U,$J,358.3,14139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14139,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,14139,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,14139,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,14140,0)
 ;;=D86.82^^53^603^50
 ;;^UTILITY(U,$J,358.3,14140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14140,1,3,0)
 ;;=3^Sarcoidosis,Multiple Cranial Nerve Palsies
 ;;^UTILITY(U,$J,358.3,14140,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,14140,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,14141,0)
 ;;=D86.84^^53^603^44
 ;;^UTILITY(U,$J,358.3,14141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14141,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,14141,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,14141,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,14142,0)
 ;;=D86.85^^53^603^42
 ;;^UTILITY(U,$J,358.3,14142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14142,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,14142,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,14142,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,14143,0)
 ;;=D86.83^^53^603^40
 ;;^UTILITY(U,$J,358.3,14143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14143,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,14143,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,14143,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,14144,0)
 ;;=D84.1^^53^603^16
 ;;^UTILITY(U,$J,358.3,14144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14144,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,14144,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,14144,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,14145,0)
 ;;=D81.810^^53^603^5
 ;;^UTILITY(U,$J,358.3,14145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14145,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,14145,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,14145,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,14146,0)
 ;;=E88.01^^53^603^2
 ;;^UTILITY(U,$J,358.3,14146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14146,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,14146,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,14146,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,14147,0)
 ;;=J09.X1^^53^603^25
 ;;^UTILITY(U,$J,358.3,14147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14147,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,14147,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,14147,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,14148,0)
 ;;=J09.X2^^53^603^26
 ;;^UTILITY(U,$J,358.3,14148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14148,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,14148,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,14148,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,14149,0)
 ;;=J09.X3^^53^603^27
